Age
Visit number vs VLDL Cholesterol Cal
N | Mean | StdDev | Median | Min | Max | Unknown | Total | |
---|---|---|---|---|---|---|---|---|
Baseline | 49 | 32.3 | ± 14.4 | 30.0 | -8.0 | 74.0 | - | 49 |
9-Month Followup | 43 | 29.6 | ± 15.4 | 25.0 | -8.0 | 61.0 | - | 43 |
18-Month Followup | 40 | 25.9 | ± 16.1 | 25.5 | -8.0 | 66.0 | - | 40 |
Randomized treatment arm vs VLDL Cholesterol Cal
Baseline
N | Mean | StdDev | Median | Min | Max | Unknown | Total | |
---|---|---|---|---|---|---|---|---|
Total | 49 | 32.3 | ± 14.4 | 30.0 | -8.0 | 74.0 | - | 49 |
Laparoscopic Gastric Banding (LGB) | 28 | 32.6 | ± 14.6 | 29.5 | 12.0 | 74.0 | - | 28 |
Continuous Positive Airway Pressure (CPAP) | 21 | 32.0 | ± 14.5 | 30.0 | -8.0 | 59.0 | - | 21 |
Randomized treatment arm vs VLDL Cholesterol Cal
9-Month Followup
N | Mean | StdDev | Median | Min | Max | Unknown | Total | |
---|---|---|---|---|---|---|---|---|
Total | 43 | 29.6 | ± 15.4 | 25.0 | -8.0 | 61.0 | - | 43 |
Laparoscopic Gastric Banding (LGB) | 25 | 30.6 | ± 15.7 | 25.0 | 11.0 | 60.0 | - | 25 |
Continuous Positive Airway Pressure (CPAP) | 18 | 28.3 | ± 15.2 | 25.0 | -8.0 | 61.0 | - | 18 |
Randomized treatment arm vs VLDL Cholesterol Cal
18-Month Followup
N | Mean | StdDev | Median | Min | Max | Unknown | Total | |
---|---|---|---|---|---|---|---|---|
Total | 40 | 25.9 | ± 16.1 | 25.5 | -8.0 | 66.0 | - | 40 |
Laparoscopic Gastric Banding (LGB) | 24 | 23.2 | ± 14.2 | 24.0 | -8.0 | 49.0 | - | 24 |
Continuous Positive Airway Pressure (CPAP) | 16 | 30.0 | ± 18.3 | 28.5 | -8.0 | 66.0 | - | 16 |
Age of the participant vs VLDL Cholesterol Cal
Baseline
N | Mean | StdDev | Median | Min | Max | Unknown | Total | |
---|---|---|---|---|---|---|---|---|
Total | 49 | 32.3 | ± 14.4 | 30.0 | -8.0 | 74.0 | - | 49 |
27.0 to 45.0 years | 13 | 37.9 | ± 15.4 | 30.0 | 21.0 | 74.0 | - | 13 |
46.0 to 50.0 years | 12 | 30.9 | ± 13.4 | 30.5 | 13.0 | 49.0 | - | 12 |
51.0 to 56.0 years | 12 | 30.5 | ± 17.7 | 32.0 | -8.0 | 58.0 | - | 12 |
57.0 to 65.0 years | 12 | 29.5 | ± 10.2 | 28.0 | 12.0 | 46.0 | - | 12 |
Age of the participant vs VLDL Cholesterol Cal
9-Month Followup
N | Mean | StdDev | Median | Min | Max | Unknown | Total | |
---|---|---|---|---|---|---|---|---|
Total | 43 | 29.6 | ± 15.4 | 25.0 | -8.0 | 61.0 | - | 43 |
28.0 to 47.0 years | 11 | 29.6 | ± 20.9 | 24.0 | -8.0 | 61.0 | - | 11 |
47.0 to 52.0 years | 11 | 28.8 | ± 15.5 | 25.0 | 11.0 | 60.0 | - | 11 |
52.0 to 58.0 years | 11 | 31.9 | ± 12.5 | 34.0 | 13.0 | 49.0 | - | 11 |
58.0 to 65.0 years | 10 | 28.0 | ± 12.8 | 24.0 | 11.0 | 54.0 | - | 10 |
Age of the participant vs VLDL Cholesterol Cal
18-Month Followup
N | Mean | StdDev | Median | Min | Max | Unknown | Total | |
---|---|---|---|---|---|---|---|---|
Total | 40 | 25.9 | ± 16.1 | 25.5 | -8.0 | 66.0 | - | 40 |
29.0 to 46.0 years | 10 | 26.3 | ± 21.3 | 27.0 | -8.0 | 60.0 | - | 10 |
47.0 to 52.0 years | 10 | 17.1 | ± 11.4 | 19.0 | -8.0 | 32.0 | - | 10 |
53.0 to 58.0 years | 10 | 34.3 | ± 15.3 | 32.5 | 14.0 | 66.0 | - | 10 |
58.0 to 65.0 years | 10 | 26.0 | ± 12.0 | 25.0 | 11.0 | 42.0 | - | 10 |
Gender of the participant vs VLDL Cholesterol Cal
Baseline
N | Mean | StdDev | Median | Min | Max | Unknown | Total | |
---|---|---|---|---|---|---|---|---|
Total | 49 | 32.3 | ± 14.4 | 30.0 | -8.0 | 74.0 | - | 49 |
Male | 28 | 34.1 | ± 16.4 | 30.5 | -8.0 | 74.0 | - | 28 |
Female | 21 | 29.9 | ± 11.1 | 29.0 | 12.0 | 49.0 | - | 21 |
Gender of the participant vs VLDL Cholesterol Cal
9-Month Followup
N | Mean | StdDev | Median | Min | Max | Unknown | Total | |
---|---|---|---|---|---|---|---|---|
Total | 43 | 29.6 | ± 15.4 | 25.0 | -8.0 | 61.0 | - | 43 |
Male | 25 | 32.0 | ± 17.5 | 25.0 | -8.0 | 61.0 | - | 25 |
Female | 18 | 26.4 | ± 11.5 | 24.0 | 11.0 | 49.0 | - | 18 |
Gender of the participant vs VLDL Cholesterol Cal
18-Month Followup
N | Mean | StdDev | Median | Min | Max | Unknown | Total | |
---|---|---|---|---|---|---|---|---|
Total | 40 | 25.9 | ± 16.1 | 25.5 | -8.0 | 66.0 | - | 40 |
Male | 25 | 26.3 | ± 19.0 | 29.0 | -8.0 | 66.0 | - | 25 |
Female | 15 | 25.3 | ± 10.3 | 23.0 | 11.0 | 49.0 | - | 15 |
Race of the participant vs VLDL Cholesterol Cal
Baseline
N | Mean | StdDev | Median | Min | Max | Unknown | Total | |
---|---|---|---|---|---|---|---|---|
Total | 46 | 32.2 | ± 14.7 | 29.5 | -8.0 | 74.0 | - | 46 |
white | 35 | 32.5 | ± 15.7 | 30.0 | -8.0 | 74.0 | - | 35 |
american indian or alaska native | - | - | - | - | - | - | - | - |
black or african american | 9 | 32.1 | ± 12.8 | 31.0 | 16.0 | 49.0 | - | 9 |
asian | 2 | 27.5 | ± 0.7 | 27.5 | 27.0 | 28.0 | - | 2 |
native hawaiian or other pacific islander | - | - | - | - | - | - | - | - |
other | - | - | - | - | - | - | - | - |
multiple | - | - | - | - | - | - | - | - |
Race of the participant vs VLDL Cholesterol Cal
9-Month Followup
N | Mean | StdDev | Median | Min | Max | Unknown | Total | |
---|---|---|---|---|---|---|---|---|
Total | 40 | 29.2 | ± 15.6 | 25.0 | -8.0 | 61.0 | - | 40 |
white | 31 | 27.8 | ± 15.6 | 25.0 | -8.0 | 61.0 | - | 31 |
american indian or alaska native | - | - | - | - | - | - | - | - |
black or african american | 8 | 35.4 | ± 15.5 | 34.0 | 15.0 | 60.0 | - | 8 |
asian | 1 | 20.0 | - | 20.0 | 20.0 | 20.0 | - | 1 |
native hawaiian or other pacific islander | - | - | - | - | - | - | - | - |
other | - | - | - | - | - | - | - | - |
multiple | - | - | - | - | - | - | - | - |
Race of the participant vs VLDL Cholesterol Cal
18-Month Followup
N | Mean | StdDev | Median | Min | Max | Unknown | Total | |
---|---|---|---|---|---|---|---|---|
Total | 37 | 25.1 | ± 16.3 | 25.0 | -8.0 | 66.0 | - | 37 |
white | 29 | 26.8 | ± 16.4 | 26.0 | -8.0 | 66.0 | - | 29 |
american indian or alaska native | - | - | - | - | - | - | - | - |
black or african american | 7 | 18.7 | ± 16.4 | 19.0 | -8.0 | 41.0 | - | 7 |
asian | 1 | 23.0 | - | 23.0 | 23.0 | 23.0 | - | 1 |
native hawaiian or other pacific islander | - | - | - | - | - | - | - | - |
other | - | - | - | - | - | - | - | - |
multiple | - | - | - | - | - | - | - | - |